These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 32419173)

  • 21. Pharmacokinetics of ciprofloxacin in ICU patients on continuous veno-venous haemodiafiltration.
    Wallis SC; Mullany DV; Lipman J; Rickard CM; Daley PJ
    Intensive Care Med; 2001 Apr; 27(4):665-72. PubMed ID: 11398692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of risk factors for vancomycin-induced nephrotoxicity.
    Park SJ; Lim NR; Park HJ; Yang JW; Kim MJ; Kim K; In YW; Lee YM
    Int J Clin Pharm; 2018 Oct; 40(5):1328-1334. PubMed ID: 29744794
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence of nephrotoxicity and association with vancomycin use in intensive care unit patients with pneumonia: retrospective analysis of the IMPACT-HAP Database.
    Cano EL; Haque NZ; Welch VL; Cely CM; Peyrani P; Scerpella EG; Ford KD; Zervos MJ; Ramirez JA; Kett DH;
    Clin Ther; 2012 Jan; 34(1):149-57. PubMed ID: 22284995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of an Antimicrobial Stewardship Program on Patient Safety in Veterans Prescribed Vancomycin.
    Fodero KE; Horey AL; Krajewski MP; Ruh CA; Sellick JA; Mergenhagen KA
    Clin Ther; 2016 Mar; 38(3):494-502. PubMed ID: 26831569
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vancomycin-associated nephrotoxicity in the critically ill: a retrospective multivariate regression analysis*.
    Hanrahan TP; Harlow G; Hutchinson J; Dulhunty JM; Lipman J; Whitehouse T; Roberts JA
    Crit Care Med; 2014 Dec; 42(12):2527-36. PubMed ID: 25083977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Continuous renal replacement therapy: does technique influence azotemic control?
    Morimatsu H; Uchino S; Bellomo R; Ronco C
    Ren Fail; 2002 Sep; 24(5):645-53. PubMed ID: 12380911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TNF-α depuration is a predictor of mortality in critically ill patients under continuous veno-venous hemodiafiltration treatment.
    Quinto BM; Iizuka IJ; Monte JC; Santos BF; Pereira V; Durão MS; Dalboni MA; Cendoroglo M; Santos OF; Batista MC
    Cytokine; 2015 Feb; 71(2):255-60. PubMed ID: 25461406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical outcomes and nephrotoxicity associated with vancomycin trough concentrations during treatment of deep-seated infections.
    Hermsen ED; Hanson M; Sankaranarayanan J; Stoner JA; Florescu MC; Rupp ME
    Expert Opin Drug Saf; 2010 Jan; 9(1):9-14. PubMed ID: 20021290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship Between Initial Vancomycin Trough Levels and Early-Onset Vancomycin-Associated Nephrotoxicity in Critically Ill Patients.
    Chuma M; Makishima M; Imai T; Tochikura N; Suzuki S; Kuwana T; Sawada N; Komatsu T; Sakaue T; Kikuchi N; Yoshida Y; Kinoshita K
    Ther Drug Monit; 2018 Feb; 40(1):109-114. PubMed ID: 29095798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Continuous infusion of ceftazidime in critically ill patients undergoing continuous venovenous haemodiafiltration: pharmacokinetic evaluation and dose recommendation.
    Mariat C; Venet C; Jehl F; Mwewa S; Lazarevic V; Diconne E; Fonsale N; Carricajo A; Guyomarc'h S; Vermesch R; Aubert G; Bidault R; Bertrand JC; Zeni F
    Crit Care; 2006 Feb; 10(1):R26. PubMed ID: 16507147
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of body weight-based vancomycin therapy and the incidence of nephrotoxicity: a retrospective study in the northwest of China.
    Dong MH; Wang JW; Wu Y; Chen BY; Yu M; Wen AD
    Int J Infect Dis; 2015 Aug; 37():125-8. PubMed ID: 26159843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of initial serum vancomycin trough concentrations and their association with initial empirical weight-based vancomycin dosing and development of nephrotoxicity in children: a multicenter retrospective study.
    Matson KL; Shaffer CL; Beck GL; Simonsen KA
    Pharmacotherapy; 2015 Mar; 35(3):337-43. PubMed ID: 25756622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Application of propofol sedation in patients undergoing continuous venous-venous haemodiafiltration].
    Zhang HT; Cheng SW; Peng L; Wu GP; Liang JX; Fu JW; Wang GY; Chen ZJ; Lü CZ
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2013 Jul; 25(7):408-10. PubMed ID: 23834938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biopsy-proven vancomycin-induced acute kidney injury: a case report and literature review.
    Sawada A; Kawanishi K; Morikawa S; Nakano T; Kodama M; Mitobe M; Taneda S; Koike J; Ohara M; Nagashima Y; Nitta K; Mochizuki T
    BMC Nephrol; 2018 Mar; 19(1):72. PubMed ID: 29587650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vancomycin-associated nephrotoxicity in non-critically ill patients admitted in a Brazilian public hospital: A prospective cohort study.
    de Almeida CDC; Simões E Silva AC; de Queiroz Oliveira JA; Batista ISF; Pereira FH; Gonçalves JE; Nobre V; Martins MAP
    PLoS One; 2019; 14(9):e0222095. PubMed ID: 31487314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the incidence of vancomycin-induced nephrotoxicity in hospitalized patients with and without concomitant piperacillin-tazobactam.
    Burgess LD; Drew RH
    Pharmacotherapy; 2014 Jul; 34(7):670-6. PubMed ID: 24855041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trough concentration over 12.1 mg/L is a major risk factor of vancomycin-related nephrotoxicity in patients with therapeutic drug monitoring.
    Han HK; An H; Shin KH; Shin D; Lee SH; Kim JH; Cho SH; Kang HR; Jang IJ; Yu KS; Lim KS
    Ther Drug Monit; 2014 Oct; 36(5):606-11. PubMed ID: 24577126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nephrotoxicity of piperacillin/tazobactam combined with vancomycin: should it be a concern?
    Balcı C; Uzun Ö; Arıcı M; Hayran SA; Yüce D; Ünal S
    Int J Antimicrob Agents; 2018 Aug; 52(2):180-184. PubMed ID: 29649586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A propensity-matched cohort study of vancomycin-associated nephrotoxicity in neonates.
    Constance JE; Balch AH; Stockmann C; Linakis MW; Korgenski EK; Roberts JK; Ward RM; Sherwin CM; Spigarelli MG
    Arch Dis Child Fetal Neonatal Ed; 2016 May; 101(3):F236-43. PubMed ID: 26400103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-dose intravenous vancomycin therapy and the risk of nephrotoxicity.
    Rostas SE; Kubiak DW; Calderwood MS
    Clin Ther; 2014 Jul; 36(7):1098-101. PubMed ID: 24931573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.